Concepedia

Dean Y. Maeda

DY

Statistics

Publications

34

Citations

3K

H-Index

21

Active since

2000

Affiliations

Syntrix Biosystems (United States)(Current)

University of Maryland, Baltimore

Center for Cancer Research

The University of Texas MD Anderson Cancer Center

National Cancer Institute

Dean Y. Maeda is an author at Syntrix Biosystems (United States) specializing in medicine, pharmacology, and oncology.

Publications per year

2000–2024

34

Publications

34

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 610 citations · Full text

Medicine, Cancer Biology, Oncology +16

Effective combinatorial immunotherapy for castration-resistant prostate cancer

Xin Lü, James W. Horner, Erin Paul et al. · Nature · 2017 · 547 citations · Full text

Medicine, Oncology, Urology +14

Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits Pain

Susan M. Huang, Tiziana Bisogno, Timothy J. Petros et al. · Journal of Biological Chemistry · 2001 · 336 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz et al. · Clinical Cancer Research · 2019 · 270 citations · Full text

Medicine, Immunology, Oncology +16

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

Lillian Sun, Paúl E. Clavijo, Yvette Robbins et al. · JCI Insight · 2019 · 232 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 34